What Is Copper Storage Disease in Dogs?

Copper storage disease in dogs is a condition where copper accumulates in the liver because the body can’t excrete it properly. Over time, the buildup damages liver cells, triggers inflammation, and can progress to chronic hepatitis or cirrhosis. Some breeds are genetically predisposed, but the condition can affect any dog, and it often goes undetected until significant liver damage has already occurred.

How Copper Builds Up in the Liver

Copper is an essential trace mineral that dogs need in small amounts. Normally, the body regulates copper levels through two key proteins: one controls how much copper gets absorbed from food in the intestines, and the other controls how much gets excreted through bile. When the excretion protein doesn’t work correctly, copper has no efficient exit route. It accumulates inside liver cells, where it generates oxidative damage, essentially creating toxic free radicals that destroy cells from the inside.

As damaged liver cells die off, the body replaces them with scar tissue. This scarring (fibrosis) gradually reduces the liver’s ability to function. If the process continues unchecked, it leads to cirrhosis, where so much of the liver is scarred that it can no longer do its job filtering toxins, producing proteins, or processing nutrients.

Breeds at Higher Risk

Certain breeds carry genetic mutations that directly impair copper metabolism. Bedlington Terriers were among the first breeds identified with hereditary copper toxicosis, and they remain one of the most severely affected. Labrador Retrievers, Doberman Pinschers, and Black Russian Terriers also carry relevant genetic variants.

In Labrador Retrievers, two gene mutations play a role. One affects the protein responsible for copper absorption (ATP7A), and the other affects the protein responsible for copper excretion (ATP7B). A dog can inherit one or both variants. However, genetics don’t tell the whole story. A genome-wide study of 235 Labrador Retrievers found that the known ATP7B mutations accounted for only about 12% of the heritability of elevated liver copper. That means other genes, along with environmental factors like diet, also contribute significantly.

West Highland White Terriers, Dalmatians, and Skye Terriers are also reported to have higher rates of copper-associated liver disease, though the specific genetic mechanisms in these breeds are less well characterized. Mixed-breed dogs are not immune, especially if they have ancestry from predisposed breeds.

Signs and Symptoms

The most frustrating aspect of copper storage disease is that dogs can accumulate dangerous levels of copper for months or years without showing any outward signs. During this subclinical phase, the liver is quietly sustaining damage while the dog appears healthy. Many cases are discovered incidentally through routine bloodwork or during workups for unrelated issues.

When symptoms do appear, they reflect liver dysfunction and may include:

  • Loss of appetite and weight loss
  • Lethargy and general weakness
  • Vomiting or diarrhea
  • Increased thirst and urination
  • Jaundice (yellowing of the gums, whites of the eyes, or inner ear flaps)
  • Fluid buildup in the abdomen (giving the belly a swollen appearance)

In acute crises, a sudden release of stored copper from damaged liver cells can flood the bloodstream, destroying red blood cells and causing anemia. Dogs in this state may have dark or orange-tinged urine and can deteriorate rapidly. By the time jaundice or abdominal fluid appear, the liver damage is typically advanced.

How It’s Diagnosed

Standard blood tests can hint at the problem but can’t confirm it. Elevated liver enzymes (particularly ALT) suggest liver damage, but plenty of other conditions raise ALT too. And not all dogs with copper accumulation have elevated ALT, especially early on. A normal ALT value does not guarantee a dog is free of copper buildup.

The definitive diagnosis requires a liver biopsy: a small piece of liver tissue is removed and examined under a microscope for copper deposits and signs of inflammation. The gold standard for measuring how much copper is present is a laboratory technique called atomic absorption spectroscopy, which requires about 50 milligrams of wet tissue. Normal canine liver copper concentrations fall below roughly 400 parts per million on a dry weight basis; levels above 1,000 ppm are considered clearly abnormal and associated with liver injury.

A less invasive option, fine needle aspiration with special copper staining, can detect copper inside individual liver cells. But it has significant limitations. It can’t assess how the copper is distributed across the liver, how much total copper is present, or how much damage has occurred. A negative result on aspiration doesn’t reliably rule out the disease.

Genetic testing is available for Labrador Retrievers, Doberman Pinschers, Black Russian Terriers, and Bedlington Terriers through the UC Davis Veterinary Genetics Laboratory. These tests identify specific variants in the ATP7A and ATP7B genes. A positive result doesn’t mean a dog will definitely develop clinical disease, but it flags increased risk and is especially useful for breeding decisions.

Treatment Options

Treatment focuses on two goals: removing the copper already stored in the liver and preventing more from accumulating. The approach depends on how advanced the disease is at diagnosis.

Copper Chelation

Chelating agents are medications that bind to copper in the body and help it get excreted through urine. D-penicillamine is the most commonly used chelator in dogs. It’s given orally, typically on an empty stomach, and treatment often continues for months because copper removal is a slow process. Some dogs experience nausea or vomiting, particularly early in treatment. Trientine is an alternative chelator used when dogs can’t tolerate D-penicillamine.

Follow-up liver biopsies are often recommended after several months of chelation to check whether copper levels are actually decreasing and whether liver inflammation is resolving.

Zinc Supplementation

Zinc works differently from chelators. Rather than pulling copper out of the liver, it prevents new copper from being absorbed in the intestines. Zinc stimulates the production of a protein called metallothionein inside intestinal cells, which binds to copper and traps it so it passes out of the body in stool instead of entering the bloodstream.

Zinc is typically used as a maintenance therapy after chelation has brought copper levels down, or in mild cases where copper is elevated but hasn’t yet caused significant damage. It needs to be given on an empty stomach, at least an hour before or two hours after meals, for proper absorption. The treatment goal is to roughly double the dog’s baseline blood zinc levels.

Dietary Changes

Diet plays a critical supporting role. The general recommendation for dogs with copper-associated liver disease is to feed a diet containing less than 1.2 milligrams of copper per 1,000 kilocalories. Several prescription liver diets meet this threshold. Foods and treats high in copper should be avoided, including organ meats (especially beef liver), shellfish, dark leafy greens, and mushrooms.

For genetically predisposed breeds, starting a lower-copper diet before disease develops can help slow or prevent copper accumulation, particularly in dogs that have tested positive for relevant gene variants.

Prognosis and Long-Term Outlook

The outcome depends heavily on when the disease is caught. Dogs diagnosed in the subclinical phase, before significant scarring has developed, can often be managed successfully with chelation, zinc, and dietary changes. Many of these dogs live normal or near-normal lifespans with ongoing monitoring.

Dogs diagnosed after cirrhosis has set in face a more guarded prognosis. Scar tissue in the liver is permanent, and while treatment can stop further copper accumulation and reduce inflammation, it can’t reverse structural damage that’s already occurred. Dogs with advanced liver failure, particularly those showing jaundice, abdominal fluid, or signs of acute copper release, may have limited treatment options.

Because the subclinical window is so long and silent, proactive screening is valuable for high-risk breeds. Genetic testing before breeding helps reduce the spread of known mutations in the population, and periodic liver enzyme checks can catch early signs of trouble in individual dogs, even though normal results don’t fully rule out the disease. For breeds like Labrador Retrievers and Bedlington Terriers, awareness of this condition is one of the most useful tools an owner can have.